Celon Pharma is a dynamically developing Polish biopharmaceutical company with the strong research and marketing orientation.
Products for development are always chosen among those offering competitive advantage or unique features differentiating them from others.
Celon Pharma is a leader in research and development what enables the creation of a broad new class of human therapeutics. Celon has built a platform to develop a wide pipeline of drug products to treat a vast array of important diseases. We invest in development of effective and innovative original drugs, which can be used in therapies of cancer, neurological disorders, diabetes and other metabolic disorders.
Our success depends largely on the development of friendly ties between employees of the company, our customers and the entire economic environment of our organisation. We are a modern company, for which management based on the principles of Corporate Social Responsibility is the main goal.